ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ACIU
#6081
AC Immune SA
2.9
3
-0.34%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
-0.34%
月次変化
-17.93%
6か月変化
+42.23%
1年の変化
+14.45%
以前の終値
2.9
4
Open
2.9
3
Bid
Ask
Low
2.9
3
High
2.9
3
ボリューム
17
マーケット
株
ヘルスケア
ACIU
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
100.41 M
366.71 M
Valuation ratios
Enterprise value
271.11 M
1.33 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
ニュース
AC Immune beyin geçirgen NLRP3 inhibitörü için faz 1 denemesine başladı
AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor
2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
Tesla and Rivian among market cap stock movers on Friday
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - AC Immune (NASDAQ:ACIU)
AC Immune hisseleri olumlu Parkinson hastalığı denemesi verileriyle yükseldi
AC Immune stock rises after positive Parkinson’s disease trial data
AC Immune’un Parkinson tedavisi hastalığın ilerlemesini yavaşlatmada umut veriyor
AC Immune’s Parkinson’s treatment shows promise in slowing disease
AC Immune (ACIU) Reports Q3 Loss, Lags Revenue Estimates
Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release